XML 16 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Condensed Unaudited Consolidated Statements of Changes in Equity - USD ($)
Share capital
Share-based payment reserve
Foreign Currency Translation Reserve
Deficit
Total
Beginning balance at Dec. 31, 2019 $ 50,616,051 $ 11,006,367 $ 287,307 $ (47,280,254) $ 14,629,471
Beginning balance, shares at Dec. 31, 2019 37,049,374        
Shares issued for cash $ 7,870       7,870
Shares issued for cash (in shares) 7,500        
Shares issued cost $ (51,913)       (51,913)
Stock-based compensation expense   1,884,570     1,884,570
Net loss for the period       (1,418,829) (1,418,829)
Foreign currency translation reserve     (1,411,147)   (1,411,147)
Ending balance at Mar. 31, 2020 $ 50,572,008 12,890,937 (1,123,840) (48,699,083) 13,640,022
Ending balance, shares at Mar. 31, 2020 37,056,874        
Beginning balance at Dec. 31, 2019 $ 50,616,051 11,006,367 287,307 (47,280,254) 14,629,471
Beginning balance, shares at Dec. 31, 2019 37,049,374        
Net loss for the period         (10,757,128)
Ending balance at Jun. 30, 2020 $ 87,054,882 13,908,718 (550,616) (58,037,382) 42,375,602
Ending balance, shares at Jun. 30, 2020 63,182,739        
Beginning balance at Mar. 31, 2020 $ 50,572,008 12,890,937 (1,123,840) (48,699,083) 13,640,022
Beginning balance, shares at Mar. 31, 2020 37,056,874        
Shares issued for cash $ 36,363,090       36,363,090
Shares issued for cash (in shares) 25,913,365        
Shares issued pursuant to exercise of warrants $ 110,246       110,246
Shares issued pursuant to exercise of warrants (in shares) 187,500        
Shares issued pursuant to exercise of options $ 9,538 (4,037)     5,501
Shares issued pursuant to exercise of options (in shares) 25,000        
Stock-based compensation expense   1,021,818     1,021,818
Net loss for the period       (9,338,299) (9,338,299)
Foreign currency translation reserve     573,224   573,224
Ending balance at Jun. 30, 2020 $ 87,054,882 13,908,718 (550,616) (58,037,382) 42,375,602
Ending balance, shares at Jun. 30, 2020 63,182,739        
Beginning balance at Dec. 31, 2020 $ 212,058,836 16,446,400 4,501,213 (110,327,159) 122,679,290
Beginning balance, shares at Dec. 31, 2020 89,309,563        
Effect of change in functional currency $ (14,539,226) 0 0 0 (14,539,226)
Ending balance at Jan. 01, 2021 $ 197,519,610 16,446,400 4,501,213 (110,327,159) 108,140,064
Ending balance, shares at Jan. 01, 2021 89,309,563        
Beginning balance at Dec. 31, 2020 $ 212,058,836 16,446,400 4,501,213 (110,327,159) 122,679,290
Beginning balance, shares at Dec. 31, 2020 89,309,563        
Ending balance at Mar. 31, 2021 $ 357,542,725 17,630,308 4,493,354 (110,507,823) 269,158,564
Ending balance, shares at Mar. 31, 2021 112,929,422        
Beginning balance at Dec. 31, 2020 $ 212,058,836 16,446,400 4,501,213 (110,327,159) 122,679,290
Beginning balance, shares at Dec. 31, 2020 89,309,563        
Net loss for the period         (11,628,049)
Ending balance at Jun. 30, 2021 $ 358,048,493 19,296,819 4,486,880 (121,955,208) 259,876,984
Ending balance, shares at Jun. 30, 2021 113,040,021        
Beginning balance at Jan. 01, 2021 $ 197,519,610 16,446,400 4,501,213 (110,327,159) 108,140,064
Beginning balance, shares at Jan. 01, 2021 89,309,563        
Shares issued for cash $ 142,493,563       142,493,563
Shares issued for cash (in shares) 20,365,495        
Shares issued pursuant to exercise of warrants $ 16,802,299 (1,164)     16,801,135
Shares issued pursuant to exercise of warrants (in shares) 2,195,640        
Shares issued pursuant to exercise of options $ 727,253 (277,794)     449,459
Shares issued pursuant to exercise of options (in shares) 1,058,724        
Stock-based compensation expense   1,462,866     1,462,866
Net loss for the period       (180,664) (180,664)
Foreign currency translation reserve     (7,859)   (7,859)
Ending balance at Mar. 31, 2021 $ 357,542,725 17,630,308 4,493,354 (110,507,823) 269,158,564
Ending balance, shares at Mar. 31, 2021 112,929,422        
Shares issued cost $ (2,887)       (2,887)
Shares issued pursuant to exercise of warrants $ 404,354       404,354
Shares issued pursuant to exercise of warrants (in shares) 88,774        
Shares issued pursuant to exercise of options $ 104,301 (53,972)     50,329
Shares issued pursuant to exercise of options (in shares) 21,825        
Stock-based compensation expense   1,720,483     1,720,483
Net loss for the period       (11,447,385) (11,447,385)
Foreign currency translation reserve     (6,474)   (6,474)
Ending balance at Jun. 30, 2021 $ 358,048,493 $ 19,296,819 $ 4,486,880 $ (121,955,208) $ 259,876,984
Ending balance, shares at Jun. 30, 2021 113,040,021